Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2008-09-30
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Dietary Supplementation With Omega-3 Fatty Acids on Symptoms of Dry Eye
NCT03141931
Effects of a Moisturizing Product on Dry Eye and Skin
NCT02683382
The Effect of Oral Zanthoxylum Schinifolium Seed Oil in Individuals With Dry Eye Disease
NCT02802150
Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome
NCT00357201
Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease
NCT03686059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SB
Sea buckthorn oil group
Sea buckthorn (Hippophaë rhamnoides) oil
Dosage 2 g/d, frequency twice/d, duration 3 months
PL
Placebo group
Placebo comparison
Placebo comparison, dosage 2 g/d, frequency twice/d, duration 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sea buckthorn (Hippophaë rhamnoides) oil
Dosage 2 g/d, frequency twice/d, duration 3 months
Placebo comparison
Placebo comparison, dosage 2 g/d, frequency twice/d, duration 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Anticholinergic drugs
* Smoking
20 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Turku Municipal Health Department/evo-funding
UNKNOWN
Turku University Hospital
OTHER_GOV
Finnsusp Ltd.
INDUSTRY
Aromtech Ltd.
INDUSTRY
Shiny Horse Ltd
UNKNOWN
Valioravinto Ltd
UNKNOWN
The Finnish Funding Agency for Technology and Innovation (TEKES)
OTHER_GOV
University of Turku
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Turku
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heikki P Kallio, Professor
Role: STUDY_DIRECTOR
University of Turku
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Turku
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yang B, Kalimo KO, Mattila LM, Kallio SE, Katajisto JK, Peltola OJ, Kallio HP. Effects of dietary supplementation with sea buckthorn (Hippophae rhamnoides) seed and pulp oils on atopic dermatitis. J Nutr Biochem. 1999 Nov;10(11):622-30. doi: 10.1016/s0955-2863(99)00049-2.
Larmo PS, Jarvinen RL, Setala NL, Yang B, Viitanen MH, Engblom JR, Tahvonen RL, Kallio HP. Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. J Nutr. 2010 Aug;140(8):1462-8. doi: 10.3945/jn.109.118901. Epub 2010 Jun 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DESB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.